Generate a tailored SOP for Dr. Pankti Reid. Improve your application with a focused, well-structured draft.
Pankti Reid, MD, is an Associate Professor in the Department of Medicine at the University of Chicago, specializing in Clinical Pharmacology and Pharmacogenomics. Her clinical interests include the management of immune-related adverse events associated with cancer therapies. Dr. Reid has contributed significantly to the field through her research on the safety profiles of biologic targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cardiovascular outcomes. She has been involved in systematic literature reviews and meta-analyses to evaluate treatment outcomes in the context of cancer immunotherapy. Her publications include impactful studies on steroid-sparing immunosuppressive agents and their effects on cancer immunotherapy-related toxicities, thereby shaping guidelines for the management of these adverse effects. In addition, her work focuses on the efficacy of various treatments, including the evaluation of immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Dr. Reid actively contributes to advancing clinical practices in her field through research and education.
Department of Philosophy